Standard therapy versus autologous transplantation in multiple myeloma

Hematology/Oncology Clinics of North America

Volumn 11, Issue 1, 1997, Pages 133-146

  Attal, M ^a   Harousseau, J L ^a  

^a CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER SURVIVAL; HEMATOPOIETIC STEM CELL; HUMAN; MULTIPLE MYELOMA; PRIORITY JOURNAL;

EID: 0030887695     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70419-6     Document Type: Article

References (49)

1. R. Alexanian A. Haut A. Khan Treatment for multiple myeloma: Combination chemotherapy with different melphalan dose regimens JAMA 208 1969 1680
2. R. Alexanian M. Dimopoulous J. Hester Early myeloablative therapy for multiple myeloma Blood 84 1994 4278 4282
3. R. Alexanian M. Dimopoulos T. Smith Limited value of myeloblative therapy for late myeloma Blood 83 1994 512
4. K.C. Anderson J. Andersen R. Soiffer Monoclonal antibody–purged bone marrow transplantation therapy for multiple myeloma Blood 82 1993 2568
5. M. Attal F. Huguet D. Schlaifer Maintenance treatment with recombinant alpha interferon after autologous bone marrow transplantation for aggressive myeloma in first remission after conventional induction chemotherapy Bone Marrow Transplant 8 1991 125
6. M. Attal J.L. Harousseau Autologous transplantation in multiple myeloma Gahrton G. Durie B.G.M. Multiple Myeloma 1996 Arnold London 182
7. M. Attal J.L. Harousseau A.M. Stoppa A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma N Engl J Med 335 1996 91
8. M. Attal F. Huguet D. Schlaifer Intensive combined therapy for previously untreated aggressive myeloma Blood 79 1992 1130
9. B. Barlogie G. Gahrton Bone marrow transplantation in multiple myeloma Bone Marrow Transplant 7 1991 71
10. B. Barlogie R. Alexanian K. Dicke High-dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma Blood 70 1987 869
11. B. Barlogie R. Hall A. Zander High-dose melphalan with autologous bone marrow transplantation for multiple myeloma Blood 67 1986 1298
12. B. Barlogie R. Alexanian L. Smallwood Prognosis factors with high dose melphalan for refractory multiple myeloma Blood 72 1988 2015
13. B. Barlogie J. Crowley S. Jagannath Superior outcome after early autotransplantation (AT) with “Total Therapy” (TT) compared to standard SWOG Treatment (ST) for multiple myeloma [abstract] Blood 86 1995 207a
14. B. Barlogie R. Alexanian S. Jagannath Plasma cell dyscrasias JAMA 268 1992 46
15. W.J. Bensiger S.D. Rowley Demirert High dose therapy followed by autologous hematopoietic stem-cell infusion for patients with myeloma J Clin Oncol 14 1996 1447
16. D. Billadeau L. Quam W. Thomas Detection and quantification of malignant cells in the peripheral blood of multiple myeloma patients Blood 80 1992 1818 1824
17. J.M. Bird D. Bloxham D. Samson Molecular detection of clonally rearranged cells in peripheral blood progenitor cell harvests from multiple myeloma patients Br J Haematol 88 1994 110 116
18. B. Bjo¨rkstrand P. Ljungman J.M. Bird Double high-dose chemoradiotherapy with autologous stem cell transplantation can induce molecular remissions in multiple myeloma Bone Marrow Transplant 15 1995 367
19. B. Bjorkstrand P. Ljungman J.M. Bird Autologous stem cell transplantation in multiple myeloma: Results of the European Group for Bone Marrow Transplantation Stem Cells 13 1995 140
20. J.I. Craig K. Langlands A.C. Parker R.S. Anthony Molecular detection of tumor contamination in peripheral blood stem cell harvests Exp Haematol 22 1994 898
21. D. Cunningham R. Powles J.S. Malpas A randomized trial of maintenance therapy with Intron-A following high dose melphalan and ABMT in myeloma [abstract] Blood 84 1994 535a
22. D. Cunningham L. Paz-Ares S. Milan High dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma J Clin Oncol 12 1994 759
23. D. Cunningham L. Paz-Ares M.E. Gore High-dose melphalan for multiple myeloma: Long-term follow-up data J Clin Oncol 12 1994 764
24. M.A. Dimopoulos R. Alexanian D. Przepiorka Thiotepa, busulfan and cyclophosphamide: A new preparative regimen for autologous marrow and blood cell transplantation in high risk multiple myeloma Blood 82 1993 2324
25. J.P. Fermand S. CHevret P. Ravaud High dose chemoradiotherapy and autologous blood stem cell transplantation in multiple myeloma: Results of phase II trial involving 63 patients Blood 82 1993 2005
26. J.P. Fermand P. Ravaud S. Chevret High dose therapy (HDT) and autologous blood stem cell transplantation (ABSCT) versus conventional chemotherapy with HDT rescue in multiple myeloma: Results of a prospective randomized trial [abstract] Blood 8 1995 205a
27. Y. Gazitt C.C. Reading R. Hoffman Purified CD34+Lin−Thy+ stem cells do not contain clonal myeloma cells Blood 86 1995 381
28. A.M. Gianni C. Tarella M. Bregni High dose sequential chemotherapy, a widely applicable regimen, confers survival benefit to patients with high risk multiple myeloma J Clin Oncol 12 1994 503
29. M.E. Gore C. Viner M. Meldrum Intensive treatment of multiple myeloma and criteria for complete remission Lancet 2 1989 879
30. W.M. Gregory M.A. Richards J.S. Malpas Combination chemotherapy versus melphalan and prednisone in the treatment of multiple myeloma. An overview of published trials J Clin Oncol 10 1992 334
31. Harousseau J.L. Milpied N. Laporte J.P. Double-intensive therapy in high-risk multiple myeloma Blood 79 1992 2827
32. J.L. Harousseau M. Attal M. Divine Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: A report of the French registry on autologous transplantation in multiple myeloma Blood 85 1995 3077
33. J.L. Harousseau M. Attal M. Divine Comparison of autologous bone marrow transplantation and peripheral blood stem cell transplantation after first remission induction treatment in multiple myeloma Bone Marrow Transplant 15 1995 963
34. S. Jagannath B. Barlogie K. Dicke Autologous bone marrow transplantation in multiple myeloma: Identification of prognostic factors Blood 76 1990 1860
35. S. Jagannath D.H. Vesole L. Glenn Low risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell support Blood 80 1666 1992
36. R.M. Lemoli A. Fortuna M.R. Motta Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: Positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cells Blood 87 1996 1625
37. H.M. Lockhorst O. Muewissen L.F. Verdonck A.N. Dekker High risk multiple myeloma treated with high dose melphalan J Clin Oncol 10 1992 47 53
38. G. Marit C. Faberes J.L. Pico Autologous peripheral blood progenitor cell support following high dose chemotherapy in patients with high-risk multiple myeloma J Clin Oncol 14 1996 1306
39. T.J. McElwain R.L. Powles High-dose intravenous melphalan for plasma-cell leukaemia and myeloma Lancet 1 1983 822
40. D.E. Reece M.J. Barnett J.M. Connors Treatment of multiple myeloma with intensive chemotherapy followed by autologous bone marrow transplantation using marrow purged with 4 hydroxyperoxycyclophosphamide Bone Marrow Transplant 11 1993 139
41. D. Samson A. Newland J. Kearney Infusion of vincristine and doxorubicin with oral dexamethasone as first-line therapy for multiple myeloma Lancet 1 1989 882
42. G. Schiller R. Vescio C. Freytes Transplantation of CD34+ peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma Blood 86 1995 390 397
43. P.J. Selby T.J. McElwain A.C. Nandi Multiple myeloma treated with high dose intravenous melphalan Br J Haematol 66 1987 55 62
44. J.R. Sporn O.R. McIntyre Chemotherapy of previously untreated multiple myeloma patients: An analysis of recent treatment results Semin Oncol 13 1986 318
45. G. Tricot D. Vesole S. Jagannatth Graft-versus-myeloma effect: Proof of principle Blood 87 1996 1196
46. R.A. Vescio C.H. Hong J. Cao The hematopoietic stem cell antigen CD34 is not expressed on the malignant cells in multiple myeloma Blood 84 1994 3283
47. D. Vesole G. Tricot S. Jagannath Autotransplant in multiple myeloma: What have we learned? Blood 88 1996 838
48. D.H. Vesole B. Barlogie S. Jagannath High-dose therapy for refractory multiple myeloma: Improved prognosis with better supportive care and double transplants Blood 84 1994 950
49. A.J. Vora C.H. Toh J. Peel M. Greaves Use of granulocyte colony-stimulating factor (G-CSF) for mobilizing peripheral blood stem cells: Risk of mobilizing clonal myeloma cells in patients with bone-marrow infiltration Br J Haematol 86 1994 180